Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy.
type: Dataset
description: International audience
landing page: 0191-3123
keyword: infoeu-reposemanticsarticle
keyword: journal-articles
keyword: mesh-administration-intravesical
keyword: mesh-adult
keyword: mesh-aged
keyword: mesh-aged-80-and-over
keyword: mesh-antineoplastic-agents
keyword: mesh-bcg-vaccine
keyword: mesh-chemotherapy-adjuvant
keyword: mesh-disease-free-survival
keyword: mesh-female
keyword: mesh-humans
keyword: mesh-kaplan-meier-estimate
keyword: mesh-male
keyword: mesh-middle-aged
keyword: mesh-multivariate-analysis
keyword: mesh-neoplasm-recurrence-local
keyword: mesh-neoplasms-multiple-primary
keyword: mesh-patient-selection
keyword: mesh-proportional-hazards-models
keyword: mesh-retrospective-studies
keyword: mesh-risk-assessment
keyword: mesh-risk-factors
keyword: mesh-time-factors
keyword: mesh-treatment-outcome
keyword: mesh-urinary-bladder-neoplasms
issued: 2026-05-09T17:44:26.622485
modified: 2026-05-09T17:44:26.622490
language: en
contact point: Organization
  fn: CCSD

test_moissonnage_selune
type: Agent

Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy.
type: Distribution
format: HTML
access URL: https://riip.hal.science/pasteur-00862390
issued: 2026-05-09T17:44:26.635226
modified: 2026-05-09T17:44:26.599646